rimcazole has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achison, M; Boylan, MT; Hupp, TR; Spruce, BA | 1 |
1 other study(ies) available for rimcazole and Neoplasms
| Article | Year |
|---|---|
HIF-1alpha contributes to tumour-selective killing by the sigma receptor antagonist rimcazole.
Topics: Apoptosis; Carbazoles; Cell Line, Tumor; Epithelial Cells; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Pentazocine; Receptors, sigma; RNA Interference; Tumor Suppressor Protein p53; Up-Regulation | 2007 |